Life Technologies

New Genomic Alliance

Life Technologies announced the creation of the Genomic Cancer Care Alliance to help people battling cancer gain access to treatment options found through analysis of their genomic information. Founding partners include Fox Chase Cancer Center, Scripps Genomic Medicine, and the Translational Genomics Research Institute (TGen).The announcement came during the Consumer Genetics Conference being held June 2-4 in Boston.

Read All Close
The 2009 CSR REPORT

Life Technologies released its 2009 Global Citizenship Report, highlighting Life Technologies' organization-wide initiatives to be a leading corporate citizen and balance environmental and social issues with its overall mission to shape biological discovery and ultimately improve life.

Read All Close
Synthetic Genomics, Inc.

Life Technologies Corporation announced that it has made an equity investment in Synthetic Genomics, Inc. (SGI), a privately held company founded to commercialize synthetic genomic advances. Terms of the investment were not disclosed.

Read All Close

		Bioproduction Life Technologies is on the forefront of a quest to improve the human condition providing new bioprocess solutions, from market to molecule. Learn More.

		Drug Discovery With our integrated client solutions, you can make smarter investments to advance your drug discovery pipeline. Find out how.

		Sequencing For more than two decades the Applied Biosystems division of Life Technologies has been the leading provider of instruments across the sequencing spectrum. See the evolution.